Whole genome analysis of the effect of retinoic acid on liver fibrosis

Chinese Pharmacological Bulletin

Volumn 29, Issue 9, 2013, Pages 1213-1216

  Yu, Dong Ke ^a   Gao, Yuan ^a   Zhang, Cai Xia ^a   Zhang, Sheng Hua ^a   Zhen, Yong Zhan ^b   Shao, Rong Guang ^a   He, Hong Wei ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

Bile duct ligation; Gene chip; Gene expression profiling; Liver fibrosis; Rat; Retinoic acid; Signaling pathway

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 A1; GALACTOSE; INTEGRIN; MESSENGER RNA; OLIGONUCLEOTIDE; RETINOIC ACID; STARCH; SUCROSE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CARBOHYDRATE METABOLISM; CELL ADHESION; DOWN REGULATION; DRUG METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; LIPID METABOLISM; LIVER FIBROSIS; MICROARRAY ANALYSIS; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VITAMIN METABOLISM; WESTERN BLOTTING;

EID: 84890533010     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1001-1978.2013.09.008     Document Type: Article

References (12)

1. Schiff L, Schiff E R. Diseases of the Liver [M]. Vol. 2. Lippincott, 1993: 229.
2. Ginès P, Cárdenas A, Arroyo V, et al. Management of cirrhosis and ascites [J]. N Engl J Med, 2004, 350(16): 1646-54.
3. Kwok S K, Park M K, Cho M L, et al. Retinoic acid attenuates rheumatoid inflammation in mice [J]. J Immunol, 2012, 189(2): 1062-71.
4. Reichrath J, Lehmann B, Carlberg C, et al. Vitamins as hormones [J]. Horm Met Res, 2007, 39(2): 71-84. (Pubitemid 46535566)
5. He H, Mennone A, Boyer J L, et al. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells [J]. Hepatol, 2011, 53(2): 548-57.
6. Wang L, Potter J J, Rennie-Tankersley L, et al. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice [J]. Biochim Biophys Acta, 2007, 1772(1): 66-71. (Pubitemid 44960723)
7. Sanyal A J, Chalasani N, Kowdley K V, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis [J]. N Engl J Med, 2010, 362(18): 1675-85.
8. Wu J, Danielsson Ȧ. Inhibition of hepatic fibrogenesis: a review of pharmacologic candidates [J]. Scand J Gastroenterol, 1994, 29(5): 385-91. (Pubitemid 24144505)
9. Witek R P, Stone W C, Karaca F G, et al. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis [J]. Hepatol, 2009, 50(5): 1421-30.
10. Oakley F, Meso M, Iredale J P, et al. Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis [J]. Gastroenterol, 2005, 128(1): 108-20. (Pubitemid 40039963)
11. Roderfeld M, Weiskirchen R, Wagner S, et al. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice [J]. FASEB J, 2006, 20(3): 444-54. (Pubitemid 44933321)
12. Wang H, Dan Z, Jiang H. Effect of all-trans retinoic acid on liver fibrosis induced by com-mon bile duct ligation in rats [J]. J Huazhong Univ Sci Technol (med sci), 2008, 28(5): 553-7.